(Q46229463)
Statements
PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells (English)
Vihren N Kolev
Christian M Vidal
Jennifer E Ring
Irina M Shapiro
Jill Ricono
David T Weaver
Mahesh V Padval
Jonathan A Pachter
28 November 2014